386.02

+0.17%↑

TJX

143.91

+0.5%↑

LOW

244.21

+0.18%↑

NKE

67.39

-1.62%↓

AZO

3,803.85

-0.15%↓

386.02

+0.17%↑

TJX

143.91

+0.5%↑

LOW

244.21

+0.18%↑

NKE

67.39

-1.62%↓

AZO

3,803.85

-0.15%↓

386.02

+0.17%↑

TJX

143.91

+0.5%↑

LOW

244.21

+0.18%↑

NKE

67.39

-1.62%↓

AZO

3,803.85

-0.15%↓

386.02

+0.17%↑

TJX

143.91

+0.5%↑

LOW

244.21

+0.18%↑

NKE

67.39

-1.62%↓

AZO

3,803.85

-0.15%↓

386.02

+0.17%↑

TJX

143.91

+0.5%↑

LOW

244.21

+0.18%↑

NKE

67.39

-1.62%↓

AZO

3,803.85

-0.15%↓

Home・Akcijų sąrašas・J. Jill Inc

J. Jill Inc

Uždarymo kaina

15.96 -1.24

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

15.7

Max

16.28

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-1.2M 11M
Pardavimai	363K 154M
P/E Sektoriaus vid.	6.456 30.164
Pelnas, tenkantis vienai akcijai	0.88
Dividendų pajamingumas	1.98
Pelno marža	6.828
Darbuotojai	1,123
EBITDA	-8M 17M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+23.76% upside

Dividendai
By Dow Jones
Dividendų pajamingumas Sektoriaus vid.	1.98% 3.10%
Kitas uždarbis	2025-12-10

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-23M 233M
Ankstesnė atidarymo kaina	17.2
Ankstesnė uždarymo kaina	15.96

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

15.27 / 15.86 Palaikymas ir pasipriešinimas

J. Jill Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-28 23:50; UTC

Karštos akcijos

Stocks to Watch: Caesars, Enphase, Mondelez, Teradyne

2025-10-28 23:25; UTC

Uždarbis

SK Hynix Posts Record Earnings on Continued AI-Chip Demand

2025-10-28 23:18; UTC

Uždarbis

Booking 3Q Sales Rise as U.S. Travel Demand Stabilizes -- Update

2025-10-28 22:20; UTC

Uždarbis

Visa Sales Jump as Consumers Keep Spending -- 2nd Update

2025-10-28 22:13; UTC

Uždarbis

Wal-Mart de Mexico Net Profit Falls in 3Q

2025-10-28 21:38; UTC

Uždarbis

Correction to Visa Sales Jump Article

2025-10-28 21:17; UTC

Uždarbis

OrthoPediatrics Wins FDA Approval for Surgery Plating System; 3Q Revenue Rises

2025-10-28 21:07; UTC

Uždarbis

Visa Sales Jump as Consumers Keep Spending -- Update

2025-10-28 21:02; UTC

Uždarbis

Mondelez Tempers Outlook as Costs Rise

2025-10-28 23:51; UTC

Rinkos pokalbiai

Nikkei May Rise on Easing U.S.-China Tensions -- Market Talk

2025-10-28 23:42; UTC

Rinkos pokalbiai

Gold Edges Lower on Possible Position Adjustments Ahead of FOMC Decision -- Market Talk

2025-10-28 23:02; UTC

Uždarbis

SK Hynix: HBM4 Shipments to Start in 4Q, Ahead of Full-Scale Sales Expansion in 2026

2025-10-28 23:01; UTC

Uždarbis

SK Hynix: Completed Discussions With Key Customers About 2026 HMB Supply

2025-10-28 22:46; UTC

Uždarbis

SK Hynix: Co. Secured Full Customer Demand for Its Entire DRAM and NAND Production for Next Yr >000660.SE

2025-10-28 22:45; UTC

Uždarbis

SK Hynix 3Q Net KRW12.6T >000660.SE

2025-10-28 22:44; UTC

Uždarbis

SK Hynix 3Q Rev KRW24.44T >000660.SE

2025-10-28 22:43; UTC

Uždarbis

SK Hynix 3Q Net Profit Beat FactSet-Compiled Consensus

2025-10-28 22:42; UTC

Uždarbis

SK Hynix 3Q Net KRW12.598T Vs. Net KRW5.753T >000660.SE

2025-10-28 22:40; UTC

Uždarbis

SK Hynix 3Q Rev KRW24.449T Vs. KRW17.573T >000660.SE

2025-10-28 22:40; UTC

Uždarbis

SK Hynix 3Q Oper Pft KRW11.383T Vs. Pft KRW7.030T >000660.SE

2025-10-28 22:22; UTC

Uždarbis

Pharmaron Beijing: Higher Contributions From Clinical-Development Services Supported Results >300759.SZ

2025-10-28 22:22; UTC

Uždarbis

Pharmaron Beijing: Higher Contributions From Laboratory Services Supported Results >300759.SZ

2025-10-28 22:22; UTC

Uždarbis

Pharmaron Beijing 3Q Net CNY439.52M, Up 42.5% on Year >300759.SZ

2025-10-28 22:20; UTC

Uždarbis

Pharmaron Beijing 3Q Rev CNY3.64B, Up 13.4% on Year >300759.SZ

2025-10-28 22:02; UTC

Uždarbis

Review & Preview: Earnings Extravaganza -- Barrons.com

2025-10-28 21:42; UTC

Rinkos pokalbiai

Uždarbis

Global Equities Roundup: Market Talk

2025-10-28 21:42; UTC

Rinkos pokalbiai

Uždarbis

Mondelez Says Cocoa Costs Peaked Heading Into Spooky Season -- Market Talk

2025-10-28 21:20; UTC

Uždarbis

Wal-Mart de Mexico 3Q EBITDA MXN25.27B, Up 3.3% on Year

2025-10-28 21:19; UTC

Uždarbis

Wal-Mart de Mexico 3Q Rev MXN241.52B, Up 4.9% on Year

2025-10-28 21:18; UTC

Uždarbis

Wal-Mart de Mexico 3Q Net MXN11.75B, Down 9.2% on Year

Akcijų palyginimas

Kainos pokytis

J. Jill Inc Prognozė

Kainos tikslas

By TipRanks

23.76% į viršų

12 mėnesių prognozė

Vidutinis 20 USD 23.76%

Aukščiausias 26 USD

Žemiausias 17 USD

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines J. Jill Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

5 ratings

Pirkti

Laikyti

Parduoti

Remiantis 5 analitikų, pateikusių J. Jill Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

15.27 / 15.86Palaikymas ir pasipriešinimas

All events are bullish.

All events are bearish.

There is one bearish event.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę J. Jill Inc

J.Jill, Inc. operates as an omnichannel retailer for women's apparel under the J.Jill brand in the United States. It offers apparel, footwear, and accessories, including scarves and jewelry. The company markets its products through retail stores, website, and catalogs. J.Jill, Inc. was founded in 1959 and is headquartered in Quincy, Massachusetts.